Get started
MEDIPHARM LABS CORPMEDIPHARM LABS CORPMEDIPHARM LABS CORP

MEDIPHARM LABS CORP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

LABS chart


Full chart

LABS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪26.72 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.035 CAD
Net income (FY)
‪−13.08 M‬ CAD
Revenue (FY)
‪33.06 M‬ CAD
Shares float
‪388.53 M‬
Beta (1Y)
1.04

Employees


Employees (FY)
166
Change (1Y)
+36 +27.69%
Revenue / Employee (1Y)
‪150.27 K‬ CAD
Net income / Employee (1Y)
‪−59.46 K‬ CAD

About MEDIPHARM LABS CORP


Sector
Process Industries
Industry
Agricultural Commodities/Milling
CEO
David A. Pidduck
Website
medipharmlabs.com
Headquarters
Barrie
Founded
2015
FIGI
BBG00K17KSD0
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

LABS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where LABS is featured.

See all sparks 

Frequently Asked Questions


The current price of LABS is 0.075 CAD — it has increased by 7.14% in the past 24 hours. Watch MEDIPHARM LABS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MEDIPHARM LABS CORP stocks are traded under the ticker LABS.
LABS stock has risen by 7.14% compared to the previous week, the month change is a 7.14% rise, over the last year MEDIPHARM LABS CORP has showed a 15.38% increase.
LABS reached its all-time high on May 14, 2019 with the price of 7.390 CAD, and its all-time low was 0.055 CAD and was reached on Jun 29, 2023. View more price dynamics on LABS chart.
See other stocks reaching their highest and lowest prices.
LABS stock is 13.33% volatile and has beta coefficient of 1.04. Track MEDIPHARM LABS CORP stock price on the chart and check out the list of the most volatile stocks — is MEDIPHARM LABS CORP there?
Yes, you can track MEDIPHARM LABS CORP financials in yearly and quarterly reports right on TradingView.
MEDIPHARM LABS CORP is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
LABS earnings for the last quarter are −0.01 CAD per share, whereas the estimation was −0.01 CAD resulting in a −27.39% surprise. The estimated earnings for the next quarter are 0.00 CAD per share. See more details about MEDIPHARM LABS CORP earnings.
MEDIPHARM LABS CORP revenue for the last quarter amounts to ‪10.35 M‬ CAD, despite the estimated figure of ‪10.26 M‬ CAD. In the next quarter, revenue is expected to reach ‪12.24 M‬ CAD.
LABS net income for the last quarter is ‪−2.58 M‬ CAD, while the quarter before that showed ‪−3.61 M‬ CAD of net income which accounts for 28.47% change. Track more MEDIPHARM LABS CORP financial stats to get the full picture.
No, LABS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 166.00 employees. See our rating of the largest employees — is MEDIPHARM LABS CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIPHARM LABS CORP EBITDA is ‪−12.28 M‬ CAD, and current EBITDA margin is −49.46%. See more stats in MEDIPHARM LABS CORP financial statements.
Like other stocks, LABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPHARM LABS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPHARM LABS CORP technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPHARM LABS CORP stock shows the neutral signal. See more of MEDIPHARM LABS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.